Dutch biotech InteRNA Technologies has raised €18.5 million ($22 million) in second-round financing as it prepares to start clinical trials of its lead drug candidate INT-1B3 for solid tumours.
We built and photographed this set for its launch. Barad-dûr is as expensive as it looks, with multiple levels that slide out to reveal a library, a throne room, a dining area, a dungeon ...
You won't want to miss this patio set deal. TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. The Walsunny ...